What is our potential next president worried about?
Robert Kennedy Jr — just kidding– never to be president, is lamenting the FDA rejection yesterday of psychedelic drugs to cure PTSD.
The FDA did reject MDMA, or Ecstasy, or Molly, because it isn’t safe, they say. For one thing, it only works under the treatment of a therapist. If there’s no therapy, MDMA is just for kicks.
According to NPR, the FDA wrote that “the available evidence fails to show that the drug is effective or that its benefits outweigh its risks.”
After the FDA decision, Kennedy wrote: “MDMA treatment for PTSD and other mental illnesses has a big drawback — a single treatment is effective. That means small profit potential compared to lifetime treatment with conventional pharmaceuticals. Maybe that’s why an FDA advisory committee shot it down. One of the committee members actually works for Johnson & Johnson.
“When I’m President the FDA will serve the public, not industry. Then we can start getting to the root of this nation’s mental health crisis.”
The DEA says: “MDMA mainly affects brain cells that use
the chemical serotonin to communicate with each other. Serotonin helps to regulate mood, aggression, sexual activity, sleep, and sensitivity to pain. Clinical studies suggest that MDMA may increase the risk of long-term, perhaps permanent, problems with memory and learning. MDMA causes changes in perception, including euphoria and increased sensitivity to touch energy, sensual and sexual arousal, need to betouched, and need for stimulation.”
